Your browser doesn't support javascript.
loading
Fasting plasma glucose is an independent predictor of survival in patients with locally advanced non-small cell lung cancer treated with concurrent chemoradiotherapy.
Bergamino, Milana; Rullan, Antonio J; Saigí, Maria; Peiró, Inmaculada; Montanya, Eduard; Palmero, Ramón; Ruffinelli, José Carlos; Navarro, Arturo; Arnaiz, María Dolores; Brao, Isabel; Aso, Samantha; Padrones, Susana; Cardenal, Felipe; Nadal, Ernest.
Affiliation
  • Bergamino M; Department of Medical Oncology, Thoracic Oncology Division, Catalan Institute of Oncology, Hospital Duran i Reynals, Avda Gran via, 199-203, L'Hospitalet, 08908, Barcelona, Spain.
  • Rullan AJ; Department of Medical Oncology, Thoracic Oncology Division, Catalan Institute of Oncology, Hospital Duran i Reynals, Avda Gran via, 199-203, L'Hospitalet, 08908, Barcelona, Spain.
  • Saigí M; Department of Medical Oncology, Thoracic Oncology Division, Catalan Institute of Oncology, Hospital Duran i Reynals, Avda Gran via, 199-203, L'Hospitalet, 08908, Barcelona, Spain.
  • Peiró I; Clinical Nutrition Unit, Catalan Institute of Oncology, Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain.
  • Montanya E; Department of Endocrinology, Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain.
  • Palmero R; Department of Clinical Sciences, University of Barcelona, Hospital Universitari de Bellvitge, IDIBELL, CIBERDEM, L'Hospitalet, Barcelona, Spain.
  • Ruffinelli JC; Department of Medical Oncology, Thoracic Oncology Division, Catalan Institute of Oncology, Hospital Duran i Reynals, Avda Gran via, 199-203, L'Hospitalet, 08908, Barcelona, Spain.
  • Navarro A; Department of Medical Oncology, Thoracic Oncology Division, Catalan Institute of Oncology, Hospital Duran i Reynals, Avda Gran via, 199-203, L'Hospitalet, 08908, Barcelona, Spain.
  • Arnaiz MD; Department of Radiation Oncology, Catalan Institute of Oncology, Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain.
  • Brao I; Department of Radiation Oncology, Catalan Institute of Oncology, Hospital Duran i Reynals, L'Hospitalet, Barcelona, Spain.
  • Aso S; Department of Medical Oncology, Thoracic Oncology Division, Catalan Institute of Oncology, Hospital Duran i Reynals, Avda Gran via, 199-203, L'Hospitalet, 08908, Barcelona, Spain.
  • Padrones S; Department of Respiratory Medicine, Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain.
  • Cardenal F; Department of Respiratory Medicine, Hospital Universitari de Bellvitge, L'Hospitalet, Barcelona, Spain.
  • Nadal E; Department of Medical Oncology, Thoracic Oncology Division, Catalan Institute of Oncology, Hospital Duran i Reynals, Avda Gran via, 199-203, L'Hospitalet, 08908, Barcelona, Spain.
BMC Cancer ; 19(1): 165, 2019 Feb 21.
Article in En | MEDLINE | ID: mdl-30791870
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platinum / Blood Glucose / Biomarkers / Carboplatin / Carcinoma, Non-Small-Cell Lung / Chemoradiotherapy / Lung Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Spain Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platinum / Blood Glucose / Biomarkers / Carboplatin / Carcinoma, Non-Small-Cell Lung / Chemoradiotherapy / Lung Neoplasms Type of study: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: BMC Cancer Journal subject: NEOPLASIAS Year: 2019 Document type: Article Affiliation country: Spain Country of publication: United kingdom